Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Reborn interim report
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(58)
•••
Comment by SamV21on Dec 30, 2021 1:11pm
86 Views
Post# 34271358

RE:RE:RE:RE:RE:Reborn interim report

RE:RE:RE:RE:RE:Reborn interim report Posting garbage from 2018 , this is when it was published scammer.
Savage97 wrote:

In addition to becoming the exclusive supplier of Sandoz, Tilray will also partner with the firm to develop new cannabis-based products that offer an alternative to smokable products that will then be distributed to Canadian hospitals and pharmacies.  Sounds familiar.  $$$.  Adding TBP and will continue scaling in after having known about them for years and astounded at their success.  GLTA



TETRA NEWS same article
The company has already started a Phase 3 clinical study designed to prove the safety and efficacy of its flagship product, smokable PPP001, designed as a therapeutic treatment for chronic and cancer pain. The company believes that PPP001 will be on the market no later than 2019.
Guy is full of empty promises and make believe deadlines ! never to be or will be reached !
Maybe when it hits a nickel some of you will see through his scam ! You obviously have to lose more money before you hold Guy accountable and reality sets in.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities